Beacon Pharmaceuticals PLC announcements
252 Dhaka Stock Exchange announcements for Beacon Pharmaceuticals PLC (BEACONPHAR) since 2010: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2021 (22).
- Credit Rating Agency of Bangladesh Limited (CRAB) has announced the Entity (surveillance) Rating of the Company as \"A1\
Credit Rating Agency of Bangladesh Limited (CRAB) has announced the Entity (surveillance) Rating of the Company as \"A1\" based on audited financial statements up to June 30, 2021; bank liability position as on November 30, 2021 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- Resumption after record date
Trading of the shares of the Company will resume on 21.12.2021 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 20.12.2021.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 1.52 for July-September 2021 as against Tk. 0.25 for July-September 2020; NOCFPS was Tk. (0.65) for July-September 2021 as against Tk. (0.68) for July-September 2020. NAV per share was Tk. 24.71 as on September 30, 2021 and Tk. 20.29 as on September 30, 2020.
- Spot News
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 15.12.2021 to 19.12.2021. Trading of the shares of the Company will remain suspended on record date i.e., 20.12.2021.
- Reschedule of Board Meeting under LR 16(1)
The Company has further informed that, the Board meeting under LR 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will now be held on December 14, 2021 at 3:00 PM instead of December 12, 2021 to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on December 12, 2021 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (29.11.2021) following its corporate declaration.
- Dividend Declaration
The Board of Directors has recommended 15% cash dividend for the year ended on June 30, 2021. Date of AGM: 29.12.2021, Time: 11:00 AM, Venue: Digital Platform. Record date: 20.12.2021. The Company has also reported EPS of Tk. 3.74, NAV per share of Tk. 23.18 and NOCFPS of Tk. 0.85 for the year ended on June 30, 2021 as against Tk. 1.65, Tk. 20.04 and Tk. 1.26 respectively for the same period of the previous year.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 28, 2021 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.
- Refer to their earlier news disseminated by DSE on 28.03.2021 regarding response to DSE's Query, the company has further
Refer to their earlier news disseminated by DSE on 28.03.2021 regarding response to DSE's Query, the company has further informed that the Syrian Arab Republic has issued GMP (Good Manufacturing Practice) Certificate to the Company for the purpose of register the Beacon Pharmaceutical Ltd. for medicine.
- Query Response
In response to a DSE query dated July 27, 2021, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike and increase in volume of shares.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 2.01 for January-March 2021 as against Tk. 0.25 for January-March 2020; EPS was Tk. 3.27 for July 2020-March 2021 as against Tk. 0.55 for July 2019-March 2020. NOCFPS was Tk. (1.05) for July 2020 -March 2021 as against Tk. (1.18) for July 2019 -March 2020. NAV per share was Tk. 22.71 as on March 31, 2021 and Tk. 18.75 as on March 31, 2020.
- Q3 Financials (Additional Information)
(Q3 Un-audited): The Company has further informed that the turnover of the Company for the period July 2020 to March 2021 has been increased by 50% from the corresponding period of previous year. On the other hand, total Operating Expenses has been increased by only 9.60% from the corresponding period of previous year. Due to drastic increase of turnover and decrease of Operating expenses for the nine month period from July 2020 to March 2021 the EPS has been increased.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on May 18, 2021 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2021.
- In response to a DSE query dated March 24, 2021 regarding clarification on recent news published in the newspaper, the C
In response to a DSE query dated March 24, 2021 regarding clarification on recent news published in the newspaper, the Company has informed that "We like to inform that a technical team of the government of Syria inspected the plant of Beacon Pharmaceuticals Limited on March 08, 2021. They expressed their satisfaction verbally on the Company?s overall operations in drugs manufacturing. (Cont. 1)
- (Continuation news of BEACONPHAR): If the Syrian government agreed we may export USD 5.00 million worth of pharmaceutica
(Continuation news of BEACONPHAR): If the Syrian government agreed we may export USD 5.00 million worth of pharmaceuticals to Syria by December, 2021 and have the potential to increase exports to USD 10.00 million within one year which may have a positive financial impact of the Company. (Cont. 2)
The first part of this announcement is missing from the archive. - (Continuation news of BEACONPHAR): But no written agreement/deal has made yet. On the other hand worldwide COVID-19 situ
(Continuation news of BEACONPHAR): But no written agreement/deal has made yet. On the other hand worldwide COVID-19 situation is going down very roughly. In this situation we are not confirm regarding this deal before signing the agreement. We also assure you, after completion of the signing ceremony with the government of Syria we will inform you and other regulatory authorities on time." (end)
The first part of this announcement is missing from the archive. - Query Response
In response to a DSE query dated March 15, 2021, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike and increase in volume of shares.
- (Q2 Un-audited): EPS was Tk. 1.01 for October-December 2020 as against Tk. 0.12 for October-December 2019; EPS was Tk. 1
(Q2 Un-audited): EPS was Tk. 1.01 for October-December 2020 as against Tk. 0.12 for October-December 2019; EPS was Tk. 1.26 for July-December 2020 as against Tk. 0.30 for July-December 2019. NOCFPS was Tk. (0.48) for July-December 2020 as against Tk. (0.30) for July-December 2019. NAV per share was Tk. 20.71 as on December 31, 2020 and Tk. 12.79 as on December 31, 2019.
- As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 28, 2021 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2020.
- The Company has informed that it has disbursed the cash dividend warrants for the year ended on June 30, 2020 to the res
The Company has informed that it has disbursed the cash dividend warrants for the year ended on June 30, 2020 to the respective shareholders through courier service.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.